Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin versus comparator for staphylococcal prosthetic joint osteomyelitis
2006-005453-30Phase 2Completed
- Sponsor
- Cubist Pharmaceuticals, Inc.
- Start
- Jan 2007
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of daptomycin in Staphylococcal Osteomyelitis and periprosthetic joint infection (PJI) (3 arms), sponsored by Cubist Pharmaceuticals, Inc. Started Jan 2007; status: completed.
02
Drugs
daptomycin
03
Conditions
Staphylococcal Osteomyelitisperiprosthetic joint infection (PJI)
Beyond the preview
Go deeper on 2006-005453-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005453-30.